|
CHMP1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.164900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.818420E-03 |
| Normal-vs-Stage2 |
1.483700E-03 |
| Normal-vs-Stage3 |
3.448500E-04 |
| Normal-vs-Stage4 |
2.33899999999565E-05 |
| Stage1-vs-Stage2 |
6.266200E-01 |
| Stage1-vs-Stage3 |
1.053770E-01 |
| Stage1-vs-Stage4 |
6.14399999999682E-05 |
| Stage2-vs-Stage3 |
4.709200E-01 |
| Stage2-vs-Stage4 |
2.182100E-02 |
| Stage3-vs-Stage4 |
5.485900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.240100E-04 |
| Normal-vs-AfricanAmerican |
4.540000E-03 |
| Normal-vs-Asian |
3.378900E-04 |
| Caucasian-vs-AfricanAmerican |
8.245000E-01 |
| Caucasian-vs-Asian |
2.986400E-01 |
| AfricanAmerican-vs-Asian |
3.506200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.379100E-04 |
| Normal-vs-Female |
9.593700E-04 |
| Male-vs-Female |
3.676800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.935870E-03 |
| Normal-vs-Age(41-60Yrs) |
5.186200E-04 |
| Normal-vs-Age(61-80Yrs) |
5.648700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.088220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.010200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.436200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.327200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.463600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.263000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.543000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.678200E-02 |
| Classical-VS-Follicular |
4.669400E-01 |
| Classical-VS-Other |
5.398800E-01 |
| Classical-VS-Normal |
9.429700E-04 |
| Tall-VS-Follicular |
4.098300E-02 |
| Tall-VS-Other |
8.026800E-01 |
| Tall-VS-Normal |
1.015280E-04 |
| Follicular-VS-Other |
1.950780E-01 |
| Follicular-VS-Normal |
5.376200E-03 |
| Other-VS-Normal |
6.635600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.974500E-04 |
| Normal-vs-N1 |
1.247740E-04 |
| N0-vs-N1 |
1.468770E-01 |
|
|
